Ovid Therapeutics Inc. Insider Trading

OVID

Last 12 months

Insiders sold 29K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. President and CEO Margaret A. Alexander sold 17K on Feb 23, 16% of their stake, outside a plan. The last open-market buy by an executive or director was in Jan 2025.

Net open-market

−29K

0 buys · 2 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

Jan 2025

Jan 27, 2025

Get an email when OVID's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Feb 23	Margaret A. Alexander President and CEO	SoldNo plan	11,656	$1.45	17K	16%	Form 4
Feb 23	Jeffrey A Rona Cbfo	SoldNo plan	8,541	$1.45	12K	5.2%	Form 4
Feb 26, 2025	Margaret A. Alexander President and COO	SoldNo plan	5,279	$0.56	3K	6.7%	Form 4
Feb 26, 2025	Jeffrey A Rona Cbfo	SoldNo plan	3,902	$0.56	2K	5.4%	Form 4
Jan 27, 2025	Margaret A. Alexander President and COO	Bought	6,810	$0.73	5K	24%	Form 4

Feb 23No plan
Margaret A. Alexander
President and CEO · sold 11,656 at $1.45
17K
16% of stake
Feb 23No plan
Jeffrey A Rona
Cbfo · sold 8,541 at $1.45
12K
5.2% of stake
Feb 26, 2025No plan
Margaret A. Alexander
President and COO · sold 5,279 at $0.56
3K
6.7% of stake
Feb 26, 2025No plan
Jeffrey A Rona
Cbfo · sold 3,902 at $0.56
2K
5.4% of stake
Jan 27, 2025
Margaret A. Alexander
President and COO · bought 6,810 at $0.73
5K
24% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch OVID, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with OVID

CompareIntrinsic value

LPCNLipocine Inc.

$1.44-1.37%40

RNACCartesian Therapeutics Inc.

$6.84+6.71%10

CPMDCannapharmaRx Inc.

$0.00+0.00%0

SCPXScorpius Holdings Inc.

$0.00+0.00%10

BSPKBespoke Extracts Inc.

$0.00+0.00%30

ATXIAvenue Therapeutics Inc.

$0.40+0.00%10

HYPDHyperion DeFi, Inc.

$3.23+5.74%25

DAREDare Bioscience Inc.

$0.66+1.83%10

Held by ETFs

OVID is in 13 US ETFs. The largest of them, with OVID's weight in each:

Spot a number that looks wrong? Check it in OVID's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing OVID

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.